Autoimmune enteropathy associated with cessation of interferon-alpha therapy in chronic hepatitis C.
Gonzalez
German
G
Cleveland Clinic Florida, Weston, FL, USA. gonzalg2@ccf.org
Castro
Fernando P
FP
Berho
Mariana
M
Petras
Robert
R
D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000139:chemically induced*; D019819:Budesonide / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced* / Q000188:drug therapy; D016099:Endoscopy, Gastrointestinal; D005938:Glucocorticoids / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011241:Prednisone / Q000627:therapeutic use
D000998:Antiviral Agents; D005938:Glucocorticoids; D016898:Interferon-alpha; D019819:Budesonide; D011241:Prednisone